Effective immediately, Alfred Sandrock, Jr., M.D.,
Ph.D., has been named Executive VP, R&D, in addition to his
responsibilities as Chief Medical Officer.
Alphonse Galdes, Ph.D., has been appointed Executive VP, Pharmaceutical Operations and Technology.
Michael D. Ehlers, M.D., Ph.D., has decided to
step down as Executive VP, R&D, and will leave Biogen effective
October 11, 2019, to pursue a new career opportunity.
Sandrock joined BIIB in 1998 and has served on Biogen’s Executive Committee since 2015.
Galdes joined the company in 1995 and has served on the Executive Committee since September 2019.
https://seekingalpha.com/news/3502852-biogen-announces-leadership-changes
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.